AUPH

Aurinia Pharmaceuticals Inc

Jun 24 • 04:00PM ET

18.62

+0.74 4.14 %

Healthcare • Biotechnology • Canada • Mid • NASD

Peers: MIRM PTCT RYTM VKTX BMRN INCY KRYS AXSM NBIX PHVS

| Held by: IWM IWO IBB JSMD VTWO FESM VHT AVSC JSML SPDW

Scroll to Statements

Index	RUT	P/E	8.61	EPS (ttm)	2.16	Insider Own	12.36%	Shs Outstand	130.77M	Perf Week	14.80%
Market Cap	2.39B	Forward P/E	15.06	EPS next Y	1.24	Insider Trans	12.09%	Shs Float	112.71M	Perf Month	22.34%
Enterprise Value	2.08B	PEG	-	EPS next Q	0.24	Inst Own	61.70%	Short Float	7.83%	Perf Quarter	31.03%
Income	298.21M	P/S	8.03	EPS this Y	-53.62%	Inst Trans	1.47%	Short Ratio	7.08	Perf Half Y	15.08%
Sales	298.30M	P/B	4.29	EPS next Y	28.75%	ROA	48.54%	Short Interest	8.82M	Perf YTD	16.74%
Book/sh	4.34	P/C	6.32	EPS next 5Y	-4.55%	ROE	64.98%	52W High	18.40 1.20%	Perf Year	131.30%
Cash/sh	2.95	P/FCF	14.34	EPS past 3/5Y	- -	ROIC	48.24%	52W Low	7.28 155.59%	Perf 3Y	101.73%
Dividend Est.	-	EV/EBITDA	13.95	Sales past 3/5Y	28.30% 41.38%	Gross Margin	89.74%	Volatility	4.86% 3.75%	Perf 5Y	28.95%
Dividend TTM	-	EV/Sales	6.99	EPS Y/Y TTM	696.05%	Oper. Margin	43.58%	ATR (14)	0.70	Perf 10Y	616.13%
Dividend Ex-Date	-	Quick Ratio	5.01	Sales Y/Y TTM	20.62%	Profit Margin	99.97%	RSI (14)	78.10	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	5.55	EPS Q/Q	53.13%	SMA20	15.50%	Beta	1.37	Target Price	17.00
Payout	0.00%	Debt/Eq	0.12	Sales Q/Q	24.40%	SMA50	17.05%	Rel Volume	3.10	Prev Close	17.88
Employees	128	LT Debt/Eq	0.09	Earnings	May 07 BMO	SMA200	26.94%	Avg Volume	1.25M	Price	18.62
IPO	Oct 20, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	28.21% 0.94%	Trades		Volume	3,855,916	Change	4.14%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)